Angiogenic inhibitors for older patients with advanced colorectal cancer: Does the age hold the stage?

Although major progress has been achieved in the treatment of advanced colorectal cancer (CRC) with the employment of antiangiogenic agents, several questions remain on the use of these drugs in older patients. Since cardiovascular, renal and other comorbidities are common in the elderly, an accurat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Aprile, Giuseppe, Fontanella, Caterina, Lutrino, Eufemia Stefania, Ferrari, Laura, Casagrande, Mariaelena, Cardellino, Giovanni Gerardo, Rosati, Gerardo, Fasola, Gianpiero
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Co., Limited 2013
Konular:
Editorial
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3706712/
https://ncbi.nlm.nih.gov/pubmed/23847406
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i14.2131
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller